Nkarta Inc (NKTX)
7.40
-0.13
(-1.73%)
USD |
NASDAQ |
May 03, 16:00
7.40
0.00 (0.00%)
After-Hours: 20:00
Nkarta 1 Year Total Returns (Daily): 52.58% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 52.58% |
May 02, 2024 | 50.00% |
May 01, 2024 | 44.87% |
April 30, 2024 | 34.95% |
April 29, 2024 | 39.80% |
April 26, 2024 | 44.63% |
April 25, 2024 | 50.22% |
April 24, 2024 | 59.69% |
April 23, 2024 | 58.49% |
April 22, 2024 | 54.93% |
April 19, 2024 | 50.93% |
April 18, 2024 | 67.17% |
April 17, 2024 | 70.50% |
April 16, 2024 | 72.35% |
April 15, 2024 | 93.14% |
April 12, 2024 | 131.8% |
April 11, 2024 | 134.7% |
April 10, 2024 | 123.9% |
April 09, 2024 | 145.8% |
April 08, 2024 | 148.9% |
April 05, 2024 | 190.7% |
April 04, 2024 | 179.8% |
April 03, 2024 | 151.6% |
April 02, 2024 | 178.6% |
April 01, 2024 | 204.8% |
Date | Value |
---|---|
March 28, 2024 | 216.1% |
March 27, 2024 | 217.6% |
March 26, 2024 | 192.9% |
March 25, 2024 | 211.3% |
March 22, 2024 | 164.7% |
March 21, 2024 | 268.8% |
March 20, 2024 | 227.9% |
March 19, 2024 | 218.2% |
March 18, 2024 | 196.9% |
March 15, 2024 | 221.0% |
March 14, 2024 | 206.7% |
March 13, 2024 | 232.5% |
March 12, 2024 | 246.6% |
March 11, 2024 | 270.4% |
March 08, 2024 | 240.2% |
March 07, 2024 | 235.1% |
March 06, 2024 | 253.0% |
March 05, 2024 | 174.8% |
March 04, 2024 | 172.1% |
March 01, 2024 | 197.2% |
February 29, 2024 | 187.6% |
February 28, 2024 | 158.8% |
February 27, 2024 | 168.5% |
February 26, 2024 | 142.7% |
February 23, 2024 | 114.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.73%
Minimum
Oct 04 2023
270.4%
Maximum
Mar 11 2024
-33.80%
Average
-54.49%
Median
Jan 13 2023
1 Year Total Returns (Daily) Benchmarks
Cutera Inc | -88.26% |
GT Biopharma Inc | -63.09% |
Outlook Therapeutics Inc | -61.61% |
IMAC Holdings Inc | -17.78% |
Capricor Therapeutics Inc | 42.45% |